Kioxia Unveils CM10 Series SSDs For AI Workloads

 

KIOXIA CM10 Series Enterprise SSD

KUALA LUMPUR, July 30 (Bernama) -- Kioxia Corporation has announced the KIOXIA CM10 Series of solid-state drives (SSDs), featuring its latest BiCS FLASH generation 10 TLC flash memory for enterprise and artificial intelligence (AI) workloads.

According to Kioxia in a statement, the new drives support the NVIDIA CMX architecture while delivering significant improvements in performance, power efficiency and cooling flexibility over the previous generation.

The drives are currently being sampled by selected customers and will be showcased at FMS: The Future of Memory and Storage in Santa Clara from Aug 4 to 6.

The KIOXIA CM10 Series is the company's first PCIe 6.0 enterprise SSD and offers direct cold-plate liquid cooling capability, enabling more efficient cooling for next-generation AI infrastructure.

The series delivers up to approximately 92 per cent higher sequential read performance and up to around 85 per cent higher random read performance, helping to accelerate data-intensive AI inference and enterprise applications while improving overall system efficiency.

As AI models continue to scale toward trillions of parameters and context windows expand to millions of tokens, the demand for high-performance context cache storage is growing rapidly.

Kioxia said the KIOXIA CM10 Series is designed to meet these evolving requirements with the performance, capacity and endurance needed for large-scale AI deployments.

-- BERNAMA

HORIZON QUANTUM TO ENHANCE QUANTUM SYSTEMS EFFICIENCY WITH QM

Horizon Quantum's CEO Dr. Joe Fitzsimons and Quantum Machines' CEO Dr. Itamar Sivan at Horizon Quantum's quantum hardware testbed

 
KUALA LUMPUR, July 30 (Bernama) -- Horizon Quantum Computing Pte Ltd (Horizon Quantum), a pioneer in software infrastructure for quantum applications, has entered into a strategic collaboration with Q.M Technologies Ltd (QM) to develop more robust and efficient quantum systems.

According to Horizon Quantum in a statement, the collaboration will leverage QM's quantum control platform and engineering expertise to develop embedded calibration technologies for its first in-house hardware testbed system, Ember-1, with the aim of delivering more reliable, continuously operating quantum systems.

Horizon Quantum Chief Executive Officer, Dr Joe Fitzsimons said this strategic collaboration provides an opportunity to contribute to the development of more stable and high-performing quantum systems.

“By bringing together Horizon Quantum’s expertise in quantum software and QM’s expertise in quantum control, I believe we can develop lightweight calibration routines that increase uptime and improve the reliability of our testbed system,” he said.

The company said it intends to develop an embedded calibration framework that enables lightweight calibration routines to be executed during normal system operation, reducing reliance on lengthy full-system calibration cycles.

By updating system parameters more frequently, the framework is designed to reduce downtime, improve operational stability and maintain high-performance operation over extended runtimes.

Horizon Quantum will also leverage QM's OPX1000 control system to support the development, with improved Ember-1 uptime expected to increase access time for Triple Alpha users.

The collaboration reflects both companies' commitment to advancing practical quantum computing by combining quantum software and control technologies to support scalable, high-performance quantum systems.

-- BERNAMA

CryptoRank Study Finds Bitget rTokens Recorded Up to 58% Lower Slippage on $50,000 Orders Across Leading Tokenized Equity Platforms

VICTORIA, Seychelles, July 28 (Bernama-GLOBE NEWSWIRE) -- Bitget, the world's largest Universal Exchange (UEX), ranked first for large-order execution in a CryptoRank study evaluating liquidity, market structure and execution quality across leading tokenized equity products. The research found that Bitget's Reality rTokens delivered the lowest simulated slippage across every comparable asset tested, recording up to 58% lower slippage on $50,000 orders than competing tokenized equity products, highlighting the growing importance of execution quality as tokenized equities continue to mature.

The report arrives as the tokenized equity market approaches $2 billion in onchain value with more than 471,000 onchain holders, reflecting growing investor demand for blockchain-based access to traditional financial assets. As tokenized stocks become more widely available across crypto exchanges, CryptoRank examined how differences in product structure, liquidity models and execution infrastructure influence the trading experience beyond simple price exposure.

The study compared tokenized stock offerings across major exchanges and found that products tracking the same underlying equities can differ significantly in investor rights, liquidity mechanisms, redemption models and execution quality. The report evaluated NVIDIA, Microsoft, Meta and Tesla, the only four assets that maintained valid two-sided order books across all venues tested. In this comparable set, Bitget's Reality rTokens consistently produced the strongest execution results for larger trades.

The report found that Bitget delivered the lowest simulated slippage across all four comparable assets for both $10,000 and $50,000 orders, while Reality rTokens recorded the highest balanced displayed liquidity within 50 basis points. CryptoRank attributed these results to Bitget's liquidity architecture, which combines exchange liquidity with NYSE and NASDAQ-linked underlying market liquidity, enabling deeper liquidity and more efficient execution for larger trades. CryptoRank also examined the legal and operational structures behind tokenized equity products, noting that similar stock tickers can represent different forms of investor claims depending on how each product is issued and settled.

“Tokenization is moving beyond access and into infrastructure," said Gracy Chen, CEO at Bitget. “If even 10% of global financial assets become tokenized by 2030, we’ll witness one of the most significant transformations in modern capital markets. The next phase of tokenization will be defined by quality of execution liquidity and market infrastructure supporting those assets. Independent research like this helps establish the benchmarks the industry needs as tokenzied markets continue to mature.”

The findings build on Bitget's continued expansion of its Stock+ ecosystem, which gives eligible users access to more than 500 tokenized stocks, ETFs, commodities and other traditional financial assets alongside cryptocurrencies through a single unified account. By combining 24/7 market access, fractional investing and NYSE and NASDAQ-linked liquidity, Bitget is building the infrastructure needed to support the next generation of tokenized capital markets.

Read the CryptoRank report here.

About Bitget

Bitget is the world's largest Universal Exchange (UEX), serving over 125 million users and offering access to over 2M crypto tokens, 500+ tokenized stocks, ETFs, commodities, FX, and precious metals such as gold. The ecosystem is committed to helping users trade smarter with its AI agent, which co-pilots trade execution. Bitget is driving crypto adoption through strategic partnerships such as MotoGP™. Aligned with its global impact strategy, Bitget has joined hands with UNICEF to support blockchain education for 1.1 million people by 2027. Bitget currently leads in the tokenized TradFi market, providing the industry's lowest fees and highest liquidity across 150 regions worldwide.

For more information, visit: Website | X | Telegram | LinkedIn | Discord

For media inquiries, please contact: media@bitget.com

Risk Warning: Digital asset prices are subject to fluctuation and may experience significant volatility. Investors are advised to only allocate funds they can afford to lose. The value of any investment may be impacted, and there is a possibility that financial objectives may not be met, nor the principal investment recovered. Independent financial advice should always be sought, and personal financial experience and standing carefully considered. Past performance is not a reliable indicator of future results. Bitget accepts no liability for any potential losses incurred. Nothing contained herein should be construed as financial advice. For further information, please refer to our Terms of Use.

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/3c8f2a89-2b0b-465f-9fe6-d03b919d5754

https://www.globenewswire.com/NewsRoom/AttachmentNg/2fd67267-7705-42b5-82f2-dc4dbe7c590b 

SOURCE: Bitget Limited

DISCLAIMER: BERNAMA MREM are not accountable for any causes of website defacement, misuse, or illegal activities connected to cryptocurrency, blockchain, tokenisation, or bitcoin. This material should not be considered as guidance or an opinion, as it does not constitute financial or investment advice. Use this information at your own risk; we are not liable for any losses or damages caused by the republication of this article.

--BERNAMA

AGC Biologics Lands Commercial Manufacturing Agreement for Yokohama Site Worth Hundreds of Millions of Dollars

 

• Commercial long-term deal with a large pharmaceutical company pursuing manufacturing and commercial regulatory approvals in major markets
• Customer commits to AGC Biologics’ new site in Yokohama for five commercial biologics programs
• Highlights growing demand for geopolitically stable supply chains, positioning Japan as an allied hub for global supply of biopharmaceuticals

YOKOHAMA, Japan, July 29 (Bernama-GLOBE NEWSWIRE) -- Ahead of the official opening of AGC Biologics’ Yokohama site, an international biopharmaceutical company has already secured half of the facility’s mammalian manufacturing capacity with a multi-year commercial contract expected to reach hundreds of millions of dollars in total value. The Contract Development and Manufacturing Organization (CDMO) will leverage its new Yokohama facility to manufacture a minimum of 35 batches per year of five biopharmaceutical products for the undisclosed customer, securing a reliable global supply chain for patients worldwide.

The agreement includes process transfer, scale-up, regulatory validation, and future commercial production. The customer will pursue multiple regulatory approvals with the EMA, FDA, MHRA, and PMDA. The aggressive manufacturing timeline includes four process performance qualifications (PPQ) campaigns in the first two years. 

Securing commercial production in Japan reflects a broader industry shift toward supply chain resilience, as global biopharmaceutical developers increasingly prioritize established, geopolitically stable manufacturing partners with locations that mitigate geopolitical, regulatory and trade risks.

“AGC Biologics has the largest global network of single-use manufacturing capacity by volume outside of China, but that’s not the full story,” said Alberto Santagostino, President and CEO of AGC Biologics. “The market is demanding capable, reliable manufacturing partners with global quality standards and geographic flexibility. This agreement reflects the strength of our network, our single-use expertise, and the strategic role Japan can play in resilient biologics supply chains. Our newest Japan site in Yokohama synthesizes all our network learning in a location of increasing interest, and that carries the intrinsic cultural value of manufacturing quality and effective delivery.”

Once operational in 2027, the Yokohama site will deploy four 2,000-liter Cytiva single-use bioreactors and two 5,000-liter Thermo Fisher Scientific DynaDrive single-use bioreactors, adding 18,000 liters to AGC Biologics’ existing capacity of single-use technology for biologics manufacturing. Select customers and guests are scheduled to be provided with the opportunity to visit the new site in December 2026, when construction is completed.

“Securing a major commercial partner for Yokohama before the site is operational is a strong signal of confidence in what this facility will offer,” said Tadashi Murano, President of AGC Life Science Company. “With the site located adjacent to the AGC Yokohama Technical Center, biopharmaceutical developers are understanding that choosing a CDMO with an established innovation ecosystem in Japan is a smart outsourcing strategy.”

The AGC Biologics’ Yokohama site was part of the biomanufacturing investments made by Japan’s Ministry of Economy, Trade and Industry in 2022. These strategic investments are designed to expand domestic production and reinforce Japan’s position as a highly trusted, long-term biologics partner for life sciences industries within allied nations.

Services available in Yokohama starting in 2027 will include:

• Mammalian development and GMP manufacturing, with two downstream lines and flexible single-use bag capacity of 18,000 liters.
• Cell therapy services with six clean rooms.
• Messenger RNA (mRNA) development and manufacturing with 2 IVT, two purification lines, and two LNP lines. 

With existing cGMP manufacturing locations in the U.S., Japan, and Europe, AGC Biologics’ track record will help kick off the manufacturing operation in Yokohama, utilizing the experience of:

• More than three decades of GMP experience.
• 100 successful regulatory inspections.
• More than 30 commercial products launched, which received more than 100 separate regulatory agency approvals.
• More than 400 products developed and manufactured for over 250 different customers.

About AGC Biologics

AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering the highest standard of service as we work side-by-side with our clients and partners, to provide friendly and expert services. We provide world-class development and manufacturing of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our global network spans the U.S., Europe, and Asia, with locations in Seattle, Washington; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba and Yokohama, Japan. AGC Biologics is a part of AGC Inc.’s Life Science Business. The Life Science Business runs eight facilities focused on biopharmaceuticals, advanced therapies, small molecule active pharmaceutical ingredients, and agrochemicals. To learn more, visit www.agcbio.com.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4834252b-9e14-45c2-987f-d437e07479e4

AGC Inc. corporate contact: info-pr@agc.com

AGC Biologics media contact: kati.sills@agc.com

SOURCE: AGC Biologics, Inc.

Learning Tree International Expands ServiceNow Training Offerings

KUALA LUMPUR, July 24 (Bernama) -- Learning Tree International, a global leader in workforce transformation, has become a ServiceNow Authorised Training Partner, expanding its capabilities to help organisations build the skills needed to maximise returns on their ServiceNow platform investments.

The partnership integrates authorised ServiceNow training into Learning Tree's portfolio of more than 600 instructor-led courses and its AI Adoption Framework, which is designed to help organisations move from artificial intelligence (AI) awareness to workforce readiness and long-term adoption.

In a statement, Learning Tree said the partnership combines technical training with workforce enablement, helping organisations improve user proficiency, support change management and strengthen adoption of ServiceNow capabilities.

Its Chief Executive Officer, David Brown said the company aims to help organisations bridge the gap between technology investment and workforce readiness, enabling them to accelerate adoption, improve operational performance and achieve measurable business outcomes from AI-enabled platforms.

Under the partnership, Learning Tree will provide authorised ServiceNow training, instructor-led workforce development aligned with business needs, and programmes linking platform knowledge with leadership, process improvement and AI readiness.

With more than 50 years of experience and a global delivery network, Learning Tree said it is well positioned to provide consistent training across regions while tailoring learning pathways for platform users, business leaders and transformation teams.

The company said the collaboration establishes a foundation for broader cooperation as demand grows for role-based ServiceNow training and AI-enabled workforce transformation, helping customers maximise long-term value from their platform investments.

-- BERNAMA

Accertify and Liminal Release First Empirical Study Proving Fraud-Cyber Convergence Works - and Defining How to Do It Right

New research across 250 senior leaders identifies four organizational behaviors associated with a 3.4x performance advantage over siloed organizations 

ITASCA, Ill., July 23 (Bernama-BUSINESS WIRE) -- Accertify, a leading fraud decisioning provider whose Predictive Yes Platform enables merchants to say yes to more good customers, more revenue, and more growth, today released The Convergence Dividend: Quantifying What Fraud-Cyber Convergence Actually Delivers, a landmark proprietary study conducted in partnership with Liminal. The research - spanning 250 Director-level and above fraud, risk, and security leaders across Retail/eCommerce, Travel, Restaurants/QSR, Entertainment & Media, and Marketplaces - is the first large-scale empirical proof that fraud-cyber convergence produces better business outcomes, and the first to identify the specific behaviors that separate top-performing organizations from the rest. 

While fraud-cyber convergence is a nearly unanimous (94%) recognized priority by respondents, the research found that many organizations lack a clear framework for how to operationalize it effectively. To identify the practices associated with the strongest outcomes, Accertify and Liminal analyzed organizational behaviors against a “Precise Yes” performance metric to capture how precisely a merchant said “yes” to their customers, defined as dollars approved for every $1 of fraud chargeback. 

The resulting analysis produced a four-pillar maturity model that identifies the operational characteristics most associated with successful fraud-cyber convergence:

• Sharing 2 or more Threat Types/Use Cases: Fraud and cyber teams share joint accountability for two or more specific threat types
• Sharing Data Through a Common Platform: Fraud and cyber data integrated onto a shared pipeline, providing a single view of the customer across the lifecycle
• Regular Discussion at the Board Level: Fraud elevated to a regular board-level agenda item
• Structural Integration: Fraud and cyber teams formally unified under the same organizational structure

Organizations demonstrating all four pillars achieve a mean Precise Yes Score of $1,540 approved per dollar of fraud lost, compared to $456 approved per dollar of fraud lost for organizations still operating in silos - a 3.4x gap. That precision advantage is driven primarily by reduction in the fraud chargeback rate: elite-tier organizations record a 62% reduction in fraud chargeback rates compared to those who have not begun fraud-cyber convergence. 

The research also finds that the sequence in which organizations adopt these pillars matters. Organizations that restructured fraud and cybersecurity teams before establishing shared data, ownership, and operational collaboration performed worse than those that maintained separate teams. This suggests that successful convergence begins with shared workflows and intelligence rather than organizational charts. 

“One finding stood out: organizations perform better when they improve how fraud and cybersecurity teams share data,” said Maryling Yu, Chief Marketing Officer of Accertify. “Providing shared visibility into signals across the customer lifecycle gives teams a more complete understanding of risk, helping them approve more good customers with confidence, reduce unnecessary friction, and drive stronger business outcomes.” 

“What the data shows is that these are operational behaviors, not structural ones,” said Filip Verley, Chief Innovation Officer of Liminal. “They don’t require a budget overhaul or a reorganization. They require two teams deciding to work on the same problems - and then building the habits that make that stick. That means there is hope that every organization who undertakes a convergence journey can get to the elite performance tier.” 

The study also establishes the first peer-benchmarked view of fraud-cyber convergence across industries, with meaningful differences in maturity between sectors. For example, retail and eCommerce organizations generally demonstrated the strongest performance, while marketplaces faced the greatest challenges balancing customer approvals and fraud losses. At the same time, the research found that 97% of organizations are already on a path to converging – suggesting that the shift is being driven by operational necessity versus executive mandates. 

The Convergence Dividend: Quantifying What Fraud-Cyber Convergence Actually Delivers can be downloaded at
Accertify.com/2026-report. 

About Accertify 

Accertify enables commerce by doing one thing extraordinarily well: pinpointing fraud. The company’s Predictive Yes Platform helps businesses say yes to more - more good customers, more revenue, and more growth - without getting burned. With more than 10 billion transactions and over $1 trillion in e-commerce processed in the last 12 months, Accertify delivers the intelligence and precision that fraud and payments teams need to say yes confidently and enable growth. Learn more at accertify.com. 

About Liminal 

Liminal is the actionable intelligence company, providing structured, expert-verified intelligence on the Identity, Fraud, and Cybersecurity markets. It gives both human leaders and AI systems a dependable alternative to generic models that fall short in high-stakes decisions. Trusted by Visa, Mastercard, Google, JPMC, and the world’s leading platforms in digital identity, Liminal was founded in 2022 and is headquartered in New York City. For more information, visit liminal.co.

View source version on businesswire.com:
https://www.businesswire.com/news/home/20260722695686/en/ 

Contact 

Media
Tylor Tourville
T2 PR
tylor@t2pr.agency 

Source : Accertify 

--BERNAMA  

JUMIO REPORTS STRONG Q2 2026 ON PLATFORM INNOVATION

KUALA LUMPUR, July 23 (Bernama) -- Jumio, an artificial intelligence (AI)-powered identity intelligence provider, has announced a strong second quarter (Q2) for 2026, driven by platform innovation, executive leadership additions, and expanded customer adoption.

Jumio in a statement said the growth in Q2 was fuelled by its vision to replace legacy identity verification with continuous, contextual and connected identity intelligence.

“The innovations we brought to market in Q2 are already having a direct impact on our customers’ revenue and their user experience, which directly benefits the bottom line and reduces fraud.

“We are providing the continuous, AI-powered protection necessary to navigate an era where digital trust is a competitive necessity,” said Jumio chief executive officer (CEO), Mark Lorion.

Jumio has expanded its platform beyond the limitations of static onboarding, introducing key innovations including global digital ID acceptance, continuous risk analysis and the future of frictionless onboarding.

In June, Jumio significantly expanded support for digital IDs globally, being the first identity intelligence provider to enable customers to accept digital IDs across more than 60 countries and territories through a single integration.

In addition, Jumio Watch, launched in April, addresses the reality that identity risk persists long after a user is first verified. By continuously analysing signals and cross-customer intelligence, Jumio Watch surfaces emerging fraud patterns that static systems miss, offering fraud teams actionable, investigation-ready insights.

The company has also expanded selfie.DONE across Latin America, demonstrating that security and user experience are not mutually exclusive. The solution removes friction from the onboarding process by enabling previously verified users to confirm their identity with just a selfie.

During Q2, Jumio also recorded significant customer growth. The company appointed Lorion as CEO at the end of April, succeeding Bala Kumar, who had served as president and interim CEO since the start of 2026 and Mike Sasaki as senior vice president of Customer Success.

-- BERNAMA